{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:06:24Z","timestamp":1792735584663,"version":"4.5.0"},"reference-count":49,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although many acute myeloid leukemia (AML) colony-forming cells (CFCs) and long-term culture\u2013initiating cells (LTC-ICs) directly isolated from patients are actively cycling, quiescent progenitors are present in most samples. In the current study,3H-thymidine (3H-Tdr) suicide assays demonstrated that most NOD\/SCID mouse leukemia-initiating cells (NOD\/SL-ICs) are quiescent in 6 of 7 AML samples. AML cells in G0, G1, and S\/G2+M were isolated from 4 of these samples using Hoechst 33342\/pyroninY staining and cell sorting. The progenitor content of each subpopulation was consistent with the 3H-Tdr suicide results, with NOD\/SL-ICs found almost exclusively among G0 cells while the cycling status of AML CFCs and LTC-ICs was more heterogeneous. Interestingly, after 72 hours in serum-free culture with or without Steel factor (SF), Flt-3 ligand (FL), and interleukin-3 (IL-3), most G0 AML cells entered active cell cycle (percentage of AML cells remaining in G0 at 72 hours, 1.2% to 37%, and 0% to 7.6% in cultures without and with growth factors [GFs], respectively) while G0 cells from normal lineage-depleted bone marrow remained quiescent in the absence of GF. All 4 AML samples showed evidence of autocrine production of 2 or more of SF, FL, IL-3, and granulocyte-macrophage colony-stimulating factor (GM-CSF). In addition, 3 of 4 samples contained an internal tandem duplication of theFLT3 gene. In summary, quiescent leukemic cells, including NOD\/SL-ICs, are present in most AML patients. Their spontaneous entry into active cell cycle in short-term culture might be explained by the deregulated GF signaling present in many AMLs.<\/jats:p>","DOI":"10.1182\/blood-2002-10-3062","type":"journal-article","created":{"date-parts":[[2003,4,2]],"date-time":"2003-04-02T18:43:59Z","timestamp":1049309039000},"page":"3142-3149","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":243,"title":["Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML)"],"prefix":"10.1182","volume":"101","author":[{"given":"Yinghui","family":"Guan","sequence":"first","affiliation":[{"name":"From the Terry Fox Laboratory, British Columbia Cancer Agency, and the Departments of Medicine and Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Gerhard","sequence":"additional","affiliation":[{"name":"From the Terry Fox Laboratory, British Columbia Cancer Agency, and the Departments of Medicine and Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna E.","family":"Hogge","sequence":"additional","affiliation":[{"name":"From the Terry Fox Laboratory, British Columbia Cancer Agency, and the Departments of Medicine and Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111617105722500_B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V62.1.1.bloodjournal6211","article-title":"Stem cells in normal and leukemic hemopoiesis.","volume":"62","author":"McCulloch","year":"1983","journal-title":"Blood."},{"key":"2019111617105722500_B2","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1182\/blood.V86.8.2906.2906","article-title":"Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations.","volume":"86","author":"Haase","year":"1995","journal-title":"Blood."},{"key":"2019111617105722500_B3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med."},{"key":"2019111617105722500_B4","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1182\/blood.V87.11.4754.bloodjournal87114754","article-title":"Characterization of a hierarchy in human acute myeloid leukemia progenitor cells.","volume":"87","author":"Sutherland","year":"1996","journal-title":"Blood."},{"key":"2019111617105722500_B5","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood.V94.5.1761","article-title":"Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic\/severe combined immunodeficient mice.","volume":"94","author":"Ailles","year":"1999","journal-title":"Blood."},{"key":"2019111617105722500_B6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0140-6736(77)92818-5","article-title":"Colony assay for proliferative blast cells circulating in myeloblastic leukemia.","volume":"1","author":"Buick","year":"1977","journal-title":"Lancet."},{"key":"2019111617105722500_B7","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V90.7.2555","article-title":"Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines.","volume":"90","author":"Ailles","year":"1997","journal-title":"Blood."},{"key":"2019111617105722500_B8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature."},{"key":"2019111617105722500_B9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0301-472X(99)00099-5","article-title":"Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.","volume":"27","author":"Ailles","year":"1999","journal-title":"Exp Hematol."},{"key":"2019111617105722500_B10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood.V52.3.592.bloodjournal523592","article-title":"Proliferative state of blast cell progenitors in acute myeloblastic leukemia (AML).","volume":"52","author":"Minden","year":"1978","journal-title":"Blood."},{"key":"2019111617105722500_B11","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood.V86.9.3314.bloodjournal8693314","article-title":"Quantitation of the quiescent fraction of long-term culture-initiating cells in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro.","volume":"86","author":"Ponchio","year":"1995","journal-title":"Blood."},{"key":"2019111617105722500_B12","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/sj.leu.2401975","article-title":"Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML).","volume":"14","author":"Guan","year":"2000","journal-title":"Leukemia."},{"key":"2019111617105722500_B13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/cyto.990020302","article-title":"Flow cytometric estimation of DNA and RNA content in intact cells stained with Hoechst 33342 and pyronin Y.","volume":"2","author":"Shapiro","year":"1981","journal-title":"Cytometry."},{"key":"2019111617105722500_B14","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood.V90.11.4384","article-title":"Functional heterogeneity of human CD34+ cells isolated in subcompartments of the G0\/G1 phase of the cell cycle.","volume":"90","author":"Gothot","year":"1997","journal-title":"Blood."},{"key":"2019111617105722500_B15","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood.V92.8.2641","article-title":"Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34+ cells in non-obese diabetic\/severe combined immune-deficient mice.","volume":"92","author":"Gothot","year":"1998","journal-title":"Blood."},{"key":"2019111617105722500_B16","volume-title":"Acute Leukemia: Approach to Diagnosis.","author":"Schumacher","year":"1990"},{"key":"2019111617105722500_B17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","article-title":"Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice.","volume":"154","author":"Shultz","year":"1995","journal-title":"J Immunol."},{"key":"2019111617105722500_B18","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood."},{"key":"2019111617105722500_B19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0888-7543(92)90160-T","article-title":"Fluorescence in situ hybridization of YAC clones after Alu-PCR amplification.","volume":"13","author":"Lengauer","year":"1992","journal-title":"Genomics."},{"key":"2019111617105722500_B20","first-page":"627","article-title":"Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD\/SCID mice.","volume":"26","author":"Verlinden","year":"1998","journal-title":"Exp Hematol."},{"key":"2019111617105722500_B21","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1073\/pnas.89.13.6192","article-title":"Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.","volume":"89","author":"Udomsakdi","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111617105722500_B22","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1073\/pnas.83.14.5306","article-title":"Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells.","volume":"83","author":"Eaves","year":"1986","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111617105722500_B23","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1182\/blood.V88.6.1944.bloodjournal8861944","article-title":"Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture.","volume":"88","author":"Terpstra","year":"1996","journal-title":"Blood."},{"key":"2019111617105722500_B24","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","article-title":"Nuclear factor-\u03baB is constitutively activated in primitive human acute myelogenous leukemia cells.","volume":"98","author":"Guzman","year":"2001","journal-title":"Blood."},{"key":"2019111617105722500_B25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.leu.2401410","article-title":"Expression of Hox genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.","volume":"13","author":"Kawagoe","year":"1999","journal-title":"Leukemia."},{"key":"2019111617105722500_B26","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1182\/blood.V89.9.3104","article-title":"Lack of expression of Thy-1 (CD90) on acute myeloid leukaemia cells with long-term proliferative ability in vitro and in vivo.","volume":"89","author":"Blair","year":"1997","journal-title":"Blood."},{"key":"2019111617105722500_B27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jnci\/87.12.895","article-title":"Telomerase activity in small-cell and non-small-cell lung cancers.","volume":"87","author":"Hiyama","year":"1995","journal-title":"J Natl Cancer Inst."},{"key":"2019111617105722500_B28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1182\/blood.V99.3.792","article-title":"Stromal derived factor-1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD\/SCID mice.","volume":"99","author":"Cashman","year":"2002","journal-title":"Blood."},{"key":"2019111617105722500_B29","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1182\/blood.V92.7.2338","article-title":"MCP-1, not MIP-1\u03b1 is the endogenous chemokine that cooperates with TGF-\u03b2 to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures.","volume":"92","author":"Cashman","year":"1998","journal-title":"Blood."},{"key":"2019111617105722500_B30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1182\/blood.V78.1.110.110","article-title":"Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer.","volume":"78","author":"Eaves","year":"1991","journal-title":"Blood."},{"key":"2019111617105722500_B31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI114186","article-title":"Participation of the cytokines interleukin 6, tumor necrosis factor-\u03b1, and interleukin 1-\u03b2 secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia.","volume":"84","author":"Oster","year":"1989","journal-title":"J Clin Invest."},{"key":"2019111617105722500_B32","first-page":"562","article-title":"Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1 \u03b2 in the autonomous growth of acute myeloblastic leukaemia cells\u2014studies using purified CD34-positive cells.","volume":"6","author":"Bradbury","year":"1992","journal-title":"Leukemia."},{"key":"2019111617105722500_B33","first-page":"90a","article-title":"Co-expression of the FLT3 receptor and its ligand FL, by primary AML cells [abstract].","volume":"98","author":"Zheng","year":"2001","journal-title":"Blood."},{"key":"2019111617105722500_B34","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V68.5.1178.1178","article-title":"Autocrine secretion of GM-CSF in acute myeloblastic leukemia.","volume":"68","author":"Young","year":"1986","journal-title":"Blood."},{"key":"2019111617105722500_B35","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM199303043280904","article-title":"Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia.","volume":"328","author":"Lowenberg","year":"1991","journal-title":"N Engl J Med."},{"key":"2019111617105722500_B36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10428199509049761","article-title":"Biological features of leukaemic cells associated with autonomous growth and reduced survival in acute myeloblastic leukaemia.","volume":"16","author":"Russell","year":"1995","journal-title":"Leuk Lymphoma."},{"key":"2019111617105722500_B37","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1182\/blood.V97.10.3075","article-title":"Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine\/paracrine manner.","volume":"97","author":"Majka","year":"2001","journal-title":"Blood."},{"key":"2019111617105722500_B38","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.leu.2401130","article-title":"Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product.","volume":"12","author":"Kiyoi","year":"1998","journal-title":"Leukemia."},{"key":"2019111617105722500_B39","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.onc.1203354","article-title":"Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines.","volume":"19","author":"Hayakawa","year":"2000","journal-title":"Oncogene."},{"key":"2019111617105722500_B40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/sj.leu.2401731","article-title":"Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene.","volume":"14","author":"Rombouts","year":"2000","journal-title":"Leukemia."},{"key":"2019111617105722500_B41","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","article-title":"The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.","volume":"98","author":"Kottaridis","year":"2001","journal-title":"Blood."},{"key":"2019111617105722500_B42","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/sj.leu.2400756","article-title":"Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia.","volume":"11","author":"Kiyoi","year":"1997","journal-title":"Leukemia."},{"key":"2019111617105722500_B43","first-page":"687a","article-title":"Cell cycle analyses and apoptosis in primitive leukemic and normal cells [abstract].","volume":"94","author":"Jordan","year":"1999","journal-title":"Blood."},{"key":"2019111617105722500_B44","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1182\/blood.V97.12.3882","article-title":"Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34+CD38\u2212 progenitor cells from patients with acute myeloid leukemia.","volume":"97","author":"Feuring-Buske","year":"2001","journal-title":"Blood."},{"key":"2019111617105722500_B45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2141.1990.tb04346.x","article-title":"MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.","volume":"75","author":"Sato","year":"1990","journal-title":"Br J Haematol."},{"key":"2019111617105722500_B46","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.1996.14.7.2150","article-title":"Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.","volume":"14","author":"Zittoun","year":"1996","journal-title":"J Clin Oncol."},{"key":"2019111617105722500_B47","first-page":"2952","article-title":"Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.","volume":"90","author":"Lowenberg","year":"1997","journal-title":"Blood."},{"key":"2019111617105722500_B48","first-page":"2722","article-title":"A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM).","volume":"91","author":"Witz","year":"1998","journal-title":"Blood."},{"key":"2019111617105722500_B49","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/sj.leu.2401474","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial).","volume":"13","author":"Thomas","year":"1999","journal-title":"Leukemia."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/8\/3142\/1268882\/h80803003142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/8\/3142\/1268882\/h80803003142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T15:23:51Z","timestamp":1682436231000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/8\/3142\/16700\/Detection-isolation-and-stimulation-of-quiescent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,15]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-10-3062","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4,15]]}}}